This site will look much better in a browser that supports web standards, but it is accessible to any browser or Internet device.

Skip to main content BNA
Search
Customize My Product List - SUBSCRIPTION REQUIRED  
Go  
     
Product Information
All Products
New Products
Corporate Law & Business
Employee Benefits
Employment & Labor Law
Environment, Health & Safety
Health Care
Human Resources
Intellectual Property
Litigation
Tax & Accounting
Documents & Research
BNA Books

Customer Service
Toll-Free Phone:
1-800-372-1033
M-F, 8:30 a.m. - 7:00 p.m. ET
(excluding most federal holidays)
customercare@bna.com

Important Links
Subscriber Access

Free Trial

Product Sample

Print Product Index

FAQs


Major Topics Covered

Reforms to Hatch-Waxman Act

Fraud and abuse investigations

FDA regulation of drug company advertising and marketing

FTC antitrust enforcement actions

Growth of generic drugs

State Medicaid formularies

Biotechnology patents

Medicare drug benefit debate

Drug pricing lawsuits by states and consumers

 Text size:       Printable Version Printable Version 

Pharmaceutical Law & Industry Report ®

Details

What this service is:

Stay informed of regulatory and litigation developments affecting the pharmaceutical and biotech industries.

What it helps you do:

Follow major actions at the federal and state level that focus on intellectual property/patent issues, drug pricing and reimbursement, FDA oversight, and Federal Trade Commission antitrust enforcement.

Keep current with marketplace news on the forces behind escalating costs and the responses from the public and private sectors.

Understand how health plans, pharmacy benefit managers, and employers develop and apply drug cost-containment strategies and modifications to health plan benefits.

Stay tuned in with "hot links" to important full-text documents on the Web, such as Federal Register notices, court decisions, and government reports.

Save hours of reading time with analytical articles on emerging case law and current litigation by practicing attorneys.

Rely on reporting that is objective and independent, as well as timely.

Product Structure

Notification: current reports providing news and developments

Formats and Frequency

Print and Web notification formats are issued and available weekly. Print current reports are indexed every six months, cumulating annually. Web current reports are archived to 1/17/2003, with archive coverage of Pharmaceutical Law & Policy Report since 7/12/2001. E-mail summaries, providing the highlights and table of contents for each report, with URLs to full text articles and documents are also available.